BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 26376365)

  • 1. A secretory leukocyte protease inhibitor variant with improved activity against lung infection.
    Camper N; Glasgow AM; Osbourn M; Quinn DJ; Small DM; McLean DT; Lundy FT; Elborn JS; McNally P; Ingram RJ; Weldon S; Taggart CC
    Mucosal Immunol; 2016 May; 9(3):669-76. PubMed ID: 26376365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased levels of secretory leucoprotease inhibitor in the Pseudomonas-infected cystic fibrosis lung are due to neutrophil elastase degradation.
    Weldon S; McNally P; McElvaney NG; Elborn JS; McAuley DF; Wartelle J; Belaaouaj A; Levine RL; Taggart CC
    J Immunol; 2009 Dec; 183(12):8148-56. PubMed ID: 20007580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-protease levels in cystic fibrosis are associated with lung function, recovery from pulmonary exacerbations and may be gender-related.
    Essilfie AT; Houston N; Maniam P; Hartel G; Okano S; Reid DW
    Respirology; 2023 Jun; 28(6):533-542. PubMed ID: 36642534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutrophil elastase reduces secretion of secretory leukoproteinase inhibitor (SLPI) by lung epithelial cells: role of charge of the proteinase-inhibitor complex.
    Sullivan AL; Dafforn T; Hiemstra PS; Stockley RA
    Respir Res; 2008 Aug; 9(1):60. PubMed ID: 18699987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protease-antiprotease imbalances differ between Cystic Fibrosis patients' upper and lower airway secretions.
    Hentschel J; Fischer N; Janhsen WK; Markert UR; Lehmann T; Sonnemann J; Böer K; Pfister W; Hipler UC; Mainz JG
    J Cyst Fibros; 2015 May; 14(3):324-33. PubMed ID: 25286826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elafin, an elastase-specific inhibitor, is cleaved by its cognate enzyme neutrophil elastase in sputum from individuals with cystic fibrosis.
    Guyot N; Butler MW; McNally P; Weldon S; Greene CM; Levine RL; O'Neill SJ; Taggart CC; McElvaney NG
    J Biol Chem; 2008 Nov; 283(47):32377-85. PubMed ID: 18799464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxia down-regulates expression of secretory leukocyte protease inhibitor in bronchial epithelial cells via TGF-β1.
    Påhlman LI; Jögi A; Gram M; Mori M; Egesten A
    BMC Pulm Med; 2015 Mar; 15():19. PubMed ID: 25851169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipopolysaccharide-related stimuli induce expression of the secretory leukocyte protease inhibitor, a macrophage-derived lipopolysaccharide inhibitor.
    Jin F; Nathan CF; Radzioch D; Ding A
    Infect Immun; 1998 Jun; 66(6):2447-52. PubMed ID: 9596701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancing the developmental competence of the early embryo using secretory leukocyte peptidase inhibitor.
    Kim HS; Ha KS; Kwon HC; Lee SJ; Kim CH; Cheon YP
    Differentiation; 2016; 92(1-2):24-34. PubMed ID: 26927923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombospondin-1 Restricts Interleukin-36γ-Mediated Neutrophilic Inflammation during Pseudomonas aeruginosa Pulmonary Infection.
    Peñaloza HF; Olonisakin TF; Bain WG; Qu Y; van der Geest R; Zupetic J; Hulver M; Xiong Z; Newstead MW; Zou C; Alder JK; Ybe JA; Standiford TJ; Lee JS
    mBio; 2021 Apr; 12(2):. PubMed ID: 33824208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-inflammatory effects of mutant forms of secretory leukocyte protease inhibitor.
    Mulligan MS; Lentsch AB; Huber-Lang M; Guo RF; Sarma V; Wright CD; Ulich TR; Ward PA
    Am J Pathol; 2000 Mar; 156(3):1033-9. PubMed ID: 10702419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Working from within: how secretory leukocyte protease inhibitor regulates the expression of pro-inflammatory genes.
    Douglas TC; Hannila SS
    Biochem Cell Biol; 2022 Feb; 100(1):1-8. PubMed ID: 34555292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secretory leukocyte protease inhibitor (SLPI), a multifunctional protein in the host defense response.
    Majchrzak-Gorecka M; Majewski P; Grygier B; Murzyn K; Cichy J
    Cytokine Growth Factor Rev; 2016 Apr; 28():79-93. PubMed ID: 26718149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A lack of secretory leukocyte protease inhibitor (SLPI) causes defects in granulocytic differentiation.
    Klimenkova O; Ellerbeck W; Klimiankou M; Ünalan M; Kandabarau S; Gigina A; Hussein K; Zeidler C; Welte K; Skokowa J
    Blood; 2014 Feb; 123(8):1239-49. PubMed ID: 24352879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between antimicrobial proteins and airway inflammation and infection in cystic fibrosis.
    Sagel SD; Sontag MK; Accurso FJ
    Pediatr Pulmonol; 2009 Apr; 44(4):402-9. PubMed ID: 19283840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pseudomonas aeruginosa exploits lipid A and muropeptides modification as a strategy to lower innate immunity during cystic fibrosis lung infection.
    Cigana C; Curcurù L; Leone MR; Ieranò T; Lorè NI; Bianconi I; Silipo A; Cozzolino F; Lanzetta R; Molinaro A; Bernardini ML; Bragonzi A
    PLoS One; 2009 Dec; 4(12):e8439. PubMed ID: 20037649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteinase 3, a potent secretagogue in airways, is present in cystic fibrosis sputum.
    Witko-Sarsat V; Halbwachs-Mecarelli L; Schuster A; Nusbaum P; Ueki I; Canteloup S; Lenoir G; Descamps-Latscha B; Nadel JA
    Am J Respir Cell Mol Biol; 1999 Apr; 20(4):729-36. PubMed ID: 10101005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of macrophage responses to bacterial lipopolysaccharide (LPS) by secretory leukocyte protease inhibitor (SLPI) is independent of its anti-protease function.
    Yang J; Zhu J; Sun D; Ding A
    Biochim Biophys Acta; 2005 Sep; 1745(3):310-7. PubMed ID: 16112212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protease inhibitory activity of secretory leukocyte protease inhibitor ameliorates murine experimental colitis by protecting the intestinal epithelial barrier.
    Ozaka S; Sonoda A; Ariki S; Kamiyama N; Hidano S; Sachi N; Ito K; Kudo Y; Minata M; Saechue B; Dewayani A; Chalalai T; Soga Y; Takahashi Y; Fukuda C; Mizukami K; Okumura R; Kayama H; Murakami K; Takeda K; Kobayashi T
    Genes Cells; 2021 Oct; 26(10):807-822. PubMed ID: 34379860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutrophil elastase and endogenous inhibitors in Behçet's disease saliva.
    Novak T; Fortune F; Bergmeier L; Khan I; Hagi-Pavli E
    Clin Exp Immunol; 2020 Oct; 202(1):93-105. PubMed ID: 32580239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.